Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Investigative Ophthalmology & Visual Science
|
August 13, 2010
Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma
Yolanda Piña, Samuel K Houston, Timothy G Murray, et al.
Journal of Neurology
|
November 22, 2019
Using personalized medicine in gliomas: a genomic approach to diagnosis and overcoming treatment resistance in a case with pleomorphic xanthoastrocytoma
Yolanda Piña, Michael J Fusco, Robert J Macaulay, et al.
Frontiers in Oncology
|
December 8, 2025
Successful response in advanced leptomeningeal disease from pleomorphic xanthoastrocytoma with BRAF/MEK inhibitors: a case report
Maria A Jacome, Robert J Macaulay, Edwin Peguero, et al.
Ophthalmic Research
|
March 27, 2009
Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature
Yolanda Piña, Colleen M Cebulla, Timothy G Murray, et al.
Oncotargets and Therapy
|
September 13, 2022
Leukoencephalopathy During Daratumumab-Based Therapy: A Case Series of Two Patients with Multiple Myeloma
Syeda Saba Kareem, Neena Viswanathan, Solmaz Sahebjam, et al.
Investigative Ophthalmology & Visual Science
|
January 24, 2012
Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors
Yolanda Piña, Christina Decatur, Timothy G Murray, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
June 16, 2012
Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors
Yolanda Piña, Samuel K Houston, Timothy G Murray, et al.
Plos One
|
November 10, 2010
Antiangiogenic activity of 2-deoxy-D-glucose
Jaime R Merchan, Krisztina Kovács, Jaclyn W Railsback, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
February 23, 2011
Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors
Samuel K Houston, Yolanda Piña, Timothy G Murray, et al.
Investigative Ophthalmology & Visual Science
|
July 11, 2008
Basic fibroblast growth factor impact on retinoblastoma progression and survival
Colleen M Cebulla, Maria-Elena Jockovich, Yolanda Piña, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Investigative Ophthalmology & Visual Science
|
August 13, 2010
Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma
Yolanda Piña, Samuel K Houston, Timothy G Murray, et al.
Journal of Neurology
|
November 22, 2019
Using personalized medicine in gliomas: a genomic approach to diagnosis and overcoming treatment resistance in a case with pleomorphic xanthoastrocytoma
Yolanda Piña, Michael J Fusco, Robert J Macaulay, et al.
Frontiers in Oncology
|
December 8, 2025
Successful response in advanced leptomeningeal disease from pleomorphic xanthoastrocytoma with BRAF/MEK inhibitors: a case report
Maria A Jacome, Robert J Macaulay, Edwin Peguero, et al.
Ophthalmic Research
|
March 27, 2009
Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature
Yolanda Piña, Colleen M Cebulla, Timothy G Murray, et al.
Oncotargets and Therapy
|
September 13, 2022
Leukoencephalopathy During Daratumumab-Based Therapy: A Case Series of Two Patients with Multiple Myeloma
Syeda Saba Kareem, Neena Viswanathan, Solmaz Sahebjam, et al.
Investigative Ophthalmology & Visual Science
|
January 24, 2012
Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors
Yolanda Piña, Christina Decatur, Timothy G Murray, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
June 16, 2012
Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors
Yolanda Piña, Samuel K Houston, Timothy G Murray, et al.
Plos One
|
November 10, 2010
Antiangiogenic activity of 2-deoxy-D-glucose
Jaime R Merchan, Krisztina Kovács, Jaclyn W Railsback, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
February 23, 2011
Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors
Samuel K Houston, Yolanda Piña, Timothy G Murray, et al.
Investigative Ophthalmology & Visual Science
|
July 11, 2008
Basic fibroblast growth factor impact on retinoblastoma progression and survival
Colleen M Cebulla, Maria-Elena Jockovich, Yolanda Piña, et al.
Page
of 4